Ligand Pharmaceuticals Inc. Company Profile | StatInvestor

Health Care & Life Sciences » Biotechnology | Ligand Pharmaceuticals Inc.

Ligand Pharmaceuticals Inc.

Ligand Pharmaceuticals Inc. Roche Contingent Value Rights
Stock Exchange	Other OTC
EPS	-
Market Cap	-
Shares Outstanding	-
Public Float	-

Ligand Pharmaceuticals Inc.Trust Beta Contingent Value Rights
Stock Exchange	Other OTC
EPS	-
Market Cap	-
Shares Outstanding	-
Public Float	-

Ligand Pharmaceuticals Inc. Glucagon Contingent Value Rights
Stock Exchange	Other OTC
EPS	-
Market Cap	-
Shares Outstanding	-
Public Float	-

Ligand Pharmaceuticals Inc.
Stock Exchange	Frankfurt Stock Exchange
EPS	-
Market Cap	-
Shares Outstanding	21.1 M
Public Float	17.73 M

Ligand Pharmaceuticals Inc.
Stock Exchange	NASDAQ Stock Market
EPS	$35.09
Market Cap	$2.29 B
Shares Outstanding	19.6 M
Public Float	21.44 M

Profile

Address	3911 Sorrento Valley Boulevard San Diego California 92121 United States
Employees	-
Website	http://www.ligand.com
Updated	07/08/2019
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M.

Financials

John L. Higgins

Chief Executive Officer & Director

John W. Kozarich

Chairman